Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo A/S
Biotech
Adcendo raises €51M series A round to pursue 'ideal' ADC target
The Novo Seeds-Ysios Capital-led financing positions Adcendo to take an anti-uPARAP ADC to clinical proof of concept in cancer patients.
Nick Paul Taylor
Apr 29, 2021 8:15am
IO Biotech raises $155M to trial IDO and PD-L1 cancer vaccines
Jan 13, 2021 7:45am
Mission Bio raises $70M to scale single-cell cancer R&D platform
Aug 14, 2020 5:37am
Novo tweaks fund to take antibiotics deeper into the clinic
Jan 6, 2020 8:42am
Novo Holdings' antibiotic resistance fund backs 3 biotechs
Jan 21, 2019 7:41am
Novo powers rare disease startup Therachon to $60M round
Aug 9, 2018 10:35am
